Analyst Ratings for AnaptysBio (ANAB)
ANAB Rating Summary
ANAB Price Target Summary
- Highest: $140.00 (Guggenheim)
- Lowest: $50.00 (Truist Securities)
- Average: $77.91
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$77.91 (+40.6%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
Avg. $ Target:
$77.91 (+40.6%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | UBS » Updated 1/12/2026 |
Michael Yee | New Coverage | Buy (N/A) |
70.00 (N/A) |
43.20 (55.41) |
28.26% | Details |
| 10/13/2025 | Barclays » Updated 3/4/2026 |
Etzer Darout | New Coverage | Overweight (N/A) |
79.00 (78.00) |
31.77 (55.41) |
74.41% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
